Noah wealth black card customer standard is 50 million. "noah wealth" is the group brand of Noah Holdings Limited. Noah wealth originated in 2003, and its member companies have successively obtained financial licenses and business development-related qualifications from China Securities Regulatory Commission and Hong Kong Securities Regulatory Commission. Facing high-net-worth people at home and abroad, it originated from China and is a globally recognized integrated financial service management group.

20 19,119,19 Asia's financial competitiveness list was announced, and noah wealth won the "20 19 Integrated Financial Services Company" award.

1. Is noah wealth reliable? Data representation is the core.

As a company specializing in providing high-end wealth management for Chinese people around the world &; By 2020, noah wealth, a comprehensive financial service institution providing asset management services, has been operating independently for 15 years, marking the anniversary of holding listing 10. With strict ethical standards, high-standard risk management and diversified all-round services, we have been sharing the long-term value brought by the growth of new economic enterprises in China for more high-net-worth investors through equity allocation.

From the data performance, Gefei Assets, a wholly-owned asset management subsidiary of Noah, has been an active participant in the capital market through close cooperation and continuous investment with the head fund since its establishment. As of June 365,438+February 0, 2020, Gefei's parent fund directly and indirectly covered 273 IPO companies; In 2020, the number of IPO companies will reach 5 1 home, including 2 1 home for science and technology innovation board and 6 for growth enterprise market, covering 69 listed companies in overseas areas, including the United States.

The special situation in 2020 makes the medical industry become the protagonist of the investment market. According to statistics, in 2020, Gefei directly or indirectly invested in 738 medical enterprises, including 22 science and technology innovation boards, 22 growth enterprise boards, 6 Shanghai Stock Exchange 16, 3 Hong Kong Stock Exchange 13 and 5 Nasdaq. The medical investment sector performed particularly well. There are 65,438+06 successful IPO companies in investment projects, accounting for 34% of the number of IPO companies directly or indirectly covered by Gefei Parent Fund this year, including the listing of six projects including Kangxinuo, New Industry Bio, Steady Medical, Li Gan Pharmaceutical, Ke Mei Bio, Kane Technology and Huitai Medical.